how are pharmacies still compounding semaglutide offer weight loss drugs at cheaper rate Compound versions of GLP-1 drugs

Legal in the U.S

Research in earlier phases or small trials include evaluation of GLP-1s for indications such as cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes

This is the latest in ongoing disputes over compounding of GLP-1 products, and claims over the booming GLP-1 market with current estimated revenue over $50 billion

Y., Marshall L

This area of physiology is particularly relevant in modern medicine, as many chronic diseases, such as cardiovascular, neurological